Robert J. Maslanski, Jr.
I specialize in partnering with small- to midsized businesses, aligning business strategy with financial strategy to ensure scalability and a solid financial infrastructure.
With a focus on growth strategy, cash management, core driver analysis with accompanying analytics, and various system implementations, businesses I partner with enjoy optimized performance and positioning for their company's overall success, whether for long-term growth or positioning for the highest-value exit.
My expertise includes:
- Strategic partnering with SMBs
- Aligning the financial strategy to the business strategy
- Analytics, key performance indicators, and data-driven insights
- Cash forecasting and sourcing
- M&A and due diligence
- ERP system implementations
- P&L optimization
- Debt restructuring and compliance
- Budgeting, Forecasting, and modeling
- Financial systems efficiency and effectiveness
I’ve enjoyed a unique blend of experience spanning large, multinational ($30B+) publicly traded pharmaceutical companies to small (up to $50M) privately held healthcare companies.
Having worked with companies of all sizes, I bring a full 360-degree view of financial strategy and implementation. I am a big proponent of using data to drive decision-making and add insights, key drivers, and predictive analytics.
As a small business specialist, I know the value of understanding all aspects of cash. This is done through accurate cash forecasting and modeling, securing access to cash for cyclical downturns, capital requirements, loan restructuring, new equity investors, and optimizing tax planning at the time of sale.
What is my value? I combine the strategic financial depth I gained from my 15 years at large enterprises with the hands-on approach required for small businesses. Whether you are challenged with cash flow or cash access, scaling for explosive growth, or preparing for an exit, I provide business owners with the leadership and partnership to exceed their goals through real outcomes.
Some examples of significant initiatives that I have led and their benefits to my clients and employers include:
- Finance Lead on a multinational resource optimization project, which led to $80M in savings through the identification and elimination of non-value-added projects
- Implemented a debt restructuring that increased cash flow by 35% for 5 years
- Identified buyer and effectuated a $10M asset portfolio sale
- Finance subject matter expert in a global SAP implementation for a $35B multinational public company
- Reduced expenses by over 30% through contract renegotiations, identification of non-core expenses, and consolidation of procurement activities
I am a 25+ year CPA and have helped organizations ranging from large multinationals ($30B) to small businesses ($5M-$50M) improve profits, prepare for sale, optimize cash, and provide insights through data analytics.
Over the last 10 years, my focus has been primarily on small to midsize companies, where I am a strategic partner to the CEOs and Boards. I concentrate on aligning the financial strategy with the business strategy, with special emphasis on forecasting short-term cash (13 weeks) and modeling long-term cash. I ensure cash demands are sufficient against revenue cycles. I also focus on capital requirements and unexpected cash draws and ensure there are plans in place to access additional cash if ever needed.
I am passionate about helping owners understand the financial impacts of their decisions and partnering with them to find a growth plan that is sustainable, scaleable, and optimizes the growth multiple.
- President and CFO, Harris Pharmaceuticals
- CFO, Panakeia, LLC, a service disabled, veteran-owned small business (SDVOSB)
- Finance Director – Business Analytics, Allergan Pharmaceuticals
- Finance Lead, Astrazeneca Pharmaceuticals
Education and Certifications:
- Certified Public Accountant
- BS, Accounting – Rutgers University, School of Business